Plug Power Inc. (NASDAQ:PLUG) reported about 93.52% or ($8.94) million declined in its quarterly net operating cash flow on a year over year basis. The net income also has considerably decreased to ($28.88) million or 240.8% when compared with the net income of ($8.47) million in the same last year quarter. So even on the basis of net income, the company has considerably underperformed to that of the S&P 500 as well as the Electrical Equipment industry. Plug Power Inc. (NASDAQ:PLUG)’s earnings per share correspondingly declined by 27.3% in the most recent quarter, on a year over year basis. Moreover, the company has reported volatile earnings in its recent quarters. Plug Power Inc. (NASDAQ:PLUG) shares after opening at $4.05 moved to $4.14 on last trade day and at the end of the day closed at $3.80. Company price to sales ratio in past twelve months was calculated as 20.57 and price to cash ratio as 109.41. Plug Power Inc. (NASDAQ:PLUG) showed a negative weekly performance of -21.00%.
Pandora Media Inc. (NYSE:P) launched its new music recommendation unit called Promoted Stations. This new unit will feature sponsor-branded listening stations whereby Pandora will receive some payments from these brands for advertising their respective stations. However, the monetary details of the deal have not been revealed. Pandora Media Inc. (NYSE:P) shares fell -8.94% in last trading session and ended the day on $22.52. P return on equity ratio is recorded as -16.50% and its return on assets is -11.80%. Pandora Media Inc. (NYSE:P) yearly performance is 53.41%.
An investigation on behalf of investors in Yelp Inc. (NYSE:YELP) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Yelp Inc. Yelp Inc. (NYSE:YELP) shares moved down -13.39% in last trading session and was closed at $52.13, while trading in range of $51.80 – $59.92. Yelp Inc. (NYSE:YELP) year to date (YTD) performance is -24.39%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Biotechnology industry. The net income has decreased by 22.7% when compared to the same quarter one year ago, dropping from -$60.45 million to -$74.16 million. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) weekly performance is -3.27%. On last trading day company shares ended up $7.09. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -9.00%. Analysts mean target price for the company is $9.06.
Leave a Reply